Innovate Biopharmaceuticals

About:

Innovate is a clinical stage biotechnology company developing novel medicines for gastroenterological and orphan disorders.

Website: http://www.innovatebiopharma.com/index.html

Top Investors: SDS Capital Partners

Description:

Innovate, a privately held clinical stage biotechnology company, is focused on developing novel gastroenterology medicines. Their pipeline includes drug candidates for Celiac Disease and for mild to moderate ulcerative colitis, along with Secretin which improves pancreatic duct visualization in MRCP procedures. The Company is led by a strong management team with extensive business and regulatory experience. Innovate has all global rights to the products which are backed by more than 150 patents in the US, EU, and Japan.

Total Funding Amount:

$32.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Raleigh, North Carolina, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)innovatebiopharma.com

Founders:

Jay Madan

Number of Employees:

1-10

Last Funding Date:

2019-04-02

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai